Bio-scriptives Repiderm
NDC Package 60608-012-00
Package Information
Bio-scriptives Repiderm is ■ clean the skin thoroughly before applying this product ■ cover the entire affected area with a think layer one to three times daily ■ because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor ■ if bothersome dryness or peelinig occurs, reduce application to once a day or every other day ■ if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor. Marketed by Biochemics, Inc., this product is identified by NDC 60608-012 and is authorized under FDA application part333D.
Identification & Billing
- RxCUI: 1038882 - benzoyl peroxide 4.4 % Topical Cream
- RxCUI: 1038882 - benzoyl peroxide 44 MG/ML Topical Cream
- RxCUI: 1038886 - Repiderm 4.4 % Topical Cream
- RxCUI: 1038886 - benzoyl peroxide 44 MG/ML Topical Cream [Repiderm]
- RxCUI: 1038886 - Repiderm 44 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60608 - Biochemics, Inc.
- 60608-012 - Bio-scriptives Repiderm
- 60608-012-00 - 56 g in 1 BOTTLE, PLASTIC
- 60608-012 - Bio-scriptives Repiderm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60608-012-00 identifies a specific commercial package of 56 g in 1 bottle, plastic of Bio-scriptives Repiderm, labeled by Biochemics, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Biochemics, Inc. on July 24, 2010. The current certification is valid through December 31, 2017.
How is this Biochemics, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60608001200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.